Home › Compare › TLVLF vs ABBV
TLVLF yields 200000000.00% · ABBV yields 3.06%● Live data
📍 TLVLF pulled ahead of the other in Year 1
Combined, TLVLF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TLVLF + ABBV for your $10,000?
Minds + Machines Group Limited owns and operates a portfolio of domain assets in British Virgin Islands, the United Kingdom, Germany, and the United States. The company's portfolio focuses on geographic domains, such as .boston, .miami, .bayern, and .nrw; professional occupations, including .law, .abogado, and .dds; consumer interests consisting of .fashion, .wedding, .vip; lifestyle comprising .fit, .surf, .yoga; outdoor activities, including .fishing, .garden, .horse; and generic names, such as .work and .casa. It offers its services through a network of registrars and distribution partners to B2B and consumer audiences. The company was formerly known as Top Level Domain Holdings Limited and changed its name to Minds + Machines Group Limited in March 2014. Minds + Machines Group Limited is based in Road Town, the British Virgin Islands.
Full TLVLF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.